S. Kanttripathi, R. K. Sahoo, and B. K. Biswal, "SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance", Drug Discovery Today, Elsevier 2022,
https://doi.org/10.1016/j.drudis.2022.05.022
Article
S. Chabattula, P. Gupta, S. Tripathi, R. Gahtori, P. Padhi, S. Mahapatra, B. K. Biswal, S. Singh, K. Dua, J. Ruokolainen, Y. Mishra, N. Jha, D. Bishi, and K. Kesari, "Anticancer therapeutic efficacy of biogenic Am-ZnO nanoparticles on 2D and 3D tumor models", Materials Today Chemistry, vol.22, no.100618, Elsevier, December 2021,
https://doi.org/10.1016/j.mtchem.2021.100618
Article
N. Nayak, A. B. Shaik, S. K. Tripathi, B. K. Biswal, M. Mishra, and D. Sarkar, "Non-cytotoxic and non-genotoxic wear debris of strontium oxide doped (Zirconia Toughened Alumina) (SrO-ZTA) implant for hip prosthesis", Materials Chemistry and Physics, vol.274, no.125187, December 2021,
https://doi.org/10.1016/j.matchemphys.2021.125187
Article
S. K. Tripathi and B. K. Biswal, "SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting ß-catenin and epithelial to mesenchymal transition in lung cancer", Life Sciences, vol.277, Elsevier, July 2021
Article
S. K. Tripathi and B. K. Biswal, "Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma", Drug Discovery Today, vol.26, Elsevier, June 2021,
https://doi.org/10.1016/j.drudis.2021.02.005
Article
M. Panda, S. K. Tripathi, and B. K. Biswal, "SOX9: An emerging driving factor from cancer progression to drug resistance", Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1875, Elsevier, April 2021,
https://doi.org/10.1016/j.bbcan.2021.188517
Article
S. K. Tripathi and B. K. Biswal, "Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent", Pharmacological Research, vol.156, no.104772, Elsevier, June 2020,
10.1016/j.phrs.2020.104772
Article
K. Pandey, S. K. Tripathi, M. Panda, and B. K. Biswal, "Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway", Toxicology In Vitro, vol.65, Elsevier, June 2020,
10.1016/j.tiv.2020.104788
Article
M. Panda, S. K. Tripathi, and B. K. Biswal, "Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation", Molecular Biology Reports, vol.47, pp.4155-4168, Springer, May 2020,
10.1007/s11033-020-05464-w
Article
S. K. Tripathi, K. R. Rengasamy, and B. K. Biswal, "Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction", Archives of Pharmacal Research, vol.43, pp.242-256, Springer, February 2020,
10.1007/s12272-020-01221-6
Article
B. K. Biswal, "Plumbagin reduces proliferation and survival of non-small cell lung carcinoma irrespective of gefitinib resistance", in National Conference on Advances in Life Sciences and Biotechnology, Rma Devi Womens University Bhubaneswar, February 2020
Inproceedings
S. K. Tripathi, S. Behera, M. Panda, G. Zengin, and B. K. Biswal, "A Comprehensive Review on Pharmacology and Toxicology of Bioactive Compounds of Lagerstroemia Speciosa(L.) Pers.", Current Traditional Medicine 2020,
10.2174/2215083806999201211213931
Article
S. K. Tripathi, K. Pandey, K. R. Rengasamy, and B. K. Biswal, "Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer", Medicinal Research Reviews, Wiley 2020,
10.1002/med.21700
Article
B. K. Biswal, S. K. Tripathi, M. Panda, and K. Pandey, "SOX9 promotes gefitinib resistance in non-small cell lung carcinoma through differential expression of epithelial to mesenchymal transition markers", in International Conference “Cancer Metastasis”, December 2019
Inproceedings
K. Pandey, S. K. Tripathi, and B. K. Biswal, "Cytotoxic and apoptotic potential of plumbagin in human pancreatic carcinoma cells through mitochondrial mediated pathway", in 4th International Conference on “Nutraceuticals and Chronic Diseases”, September 2019
Inproceedings
S. K. Tripathi, K. Pandey, M. Panda, M. Spinella, K. R. Rengasamy, and B. K. Biswal, "The potential of retinoids for combination therapy of lung cancer: updates and future directions", Pharmacological Research, vol.147, no.104331, Elsevier, September 2019,
10.1016/j.phrs.2019.104331
Article
S. K. Tripathi and B. K. Biswal, "C797S Mutation in Resistance Development to Third-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Cancer", Austin Oncology, Austin Publishing Groups, August 2019
Article
S. K. Tripathi, M. Panda, and B. K. Biswal, "Emerging role of plumbagin: cytotoxic potential and pharmaceutical relevance towards cancer therapy", Food and Chemical Toxicology, vol.125, pp.566-582, Elsevier, March 2019,
10.1016/j.fct.2019.01.018
Article
S. K. Tripathi, A. K. Mahakud, and B. K. Biswal, "A green approach towards formulation, characterization, and antimicrobial activity of poly (Lactic-co-Glycolic) acid-Alstonia scholaris based nanoparticle", Mater. Res. Express, vol.6, IOP 2019,
10.1088/2053-1591/ab30d1
Article
M. Panda and B. K. Biswal, "Cell signaling and cancer: a mechanistic insight into drug resistance", Molecular Biology Reports, Springer 2019,
10.1007/s11033-019-04958-6
Article
S. K. Tripathi, K. Pandey, M. Panda, and B. K. Biswal, "Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy", AGO-Driven Non-Coding RNAs : Codes to Decode the Therapeutics of Diseases, ch.11, pp.293-318, Elsevier 2019,
10.1016/B978-0-12-815669-8.00011-7
Inbook
P. K. Gupta, S. K. Tripathi, S. Pappuru, S. C. Chabattula, K. Govarthanan, S. Gupta, B. K. Biswal, D. Chakraborty, and R. S. Verma, "Metal-free semi-aromatic polyester as nanodrug carrier: A novel tumor targeting drug delivery vehicle for potential clinical application", Materials Science and Engineering C, vol.107, Elsevier 2019,
10.1016/j.msec.2019.110285
Article
B. K. Biswal and S. K. Tripathi, "Phytotherapeutic potential of Pterospermum acerifolium L. in human cancer cell lines through mitochondrial mediated ROS generation", in National Conference on Biodiversity, Biotechnology & Bioinformatics: Innovative and Emerging Trends-2019 2019
Inproceedings
S. K. Tripathi and B. K. Biswal, "Pterospermum acerifolium (L.) wild bark extract induces anticarcinogenic effect in human cancer cells through mitochondrial-mediated ROS generation", Molecular Biology Reports, vol.45, no.6, pp.2283-2294, Springer, December 2018,
10.1007/s11033-018-4390-6
Article
S. K. Tripathi and B. K. Biswal, "Mechanistic investigation of anticancer potential of Pterospermum acerifolium bark extract in human cancer cell lines through ROS generation and mitochondrial stress pathway", in 37th Annual convention of Indian association of cancer research and symposium. 2018
Inproceedings
S. K. Tripathi and B. K. Biswal, "Plumbagin inhibits growth and induced apoptosis through mitochondrial stress and reactive oxygen species generation in lung cancer cells", in 87 Annual Conference of Society of Biological Chemists India 2018
Inproceedings
B. K. Biswal and S. K. Tripathi, "Wnt/b-catenin: the main culprit behind Cancer Chemoresistance", Journal of Applied Microbiology and Biochemistry, vol.1, no.4, pp.16, iMedPub, September 2017,
10.21767/2576-1412.100016
Article